miglustat has been researched along with Mucopolysaccharidosis III in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Byers, S; Derrick-Roberts, A; Fletcher, J; Kaidonis, X; Ranieri, E; Sharp, P | 1 |
| Bin-Dorel, S; Decullier, E; Fouilhoux, A; Guffon, N; Guitton, J; Paillet, C | 1 |
| Jakóbkiewicz-Banecka, J; Wegrzyn, A; Wegrzyn, G | 1 |
1 review(s) available for miglustat and Mucopolysaccharidosis III
| Article | Year |
|---|---|
Substrate deprivation therapy: a new hope for patients suffering from neuronopathic forms of inherited lysosomal storage diseases.
Topics: 1-Deoxynojirimycin; Animals; Enzyme Inhibitors; Gaucher Disease; Genistein; Humans; Lysosomal Storage Diseases; Lysosomes; Mucopolysaccharidosis III; Niemann-Pick Diseases; Sandhoff Disease; Tay-Sachs Disease | 2007 |
1 trial(s) available for miglustat and Mucopolysaccharidosis III
| Article | Year |
|---|---|
Evaluation of miglustat treatment in patients with type III mucopolysaccharidosis: a randomized, double-blind, placebo-controlled study.
Topics: 1-Deoxynojirimycin; alpha-Glucosidases; Brain; Child; Child, Preschool; Cognition; Double-Blind Method; Enzyme Inhibitors; Female; Glycoside Hydrolase Inhibitors; Humans; Magnetic Resonance Imaging; Male; Mucopolysaccharidosis III; Neuropsychological Tests; Sleep Wake Disorders | 2011 |
1 other study(ies) available for miglustat and Mucopolysaccharidosis III
| Article | Year |
|---|---|
N-butyldeoxynojirimycin treatment restores the innate fear response and improves learning in mucopolysaccharidosis IIIA mice.
Topics: 1-Deoxynojirimycin; Analysis of Variance; Animals; Brain; Chemokine CCL3; Disease Models, Animal; Fear; Gangliosides; Glucosyltransferases; Glycoside Hydrolase Inhibitors; Interleukin-1beta; Maze Learning; Mice; Mucopolysaccharidosis III | 2016 |